These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35535525)

  • 1. Safety of COVID-19 vaccines and disease flares after vaccines in children with rheumatic disease.
    Arslanoglu Aydin E; Baglan E; Bagrul I; Tuncez S; Ozdel S; Bulbul M
    Postgrad Med; 2022 Aug; 134(6):616-621. PubMed ID: 35535525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review.
    Xie Y; Liu Y; Liu Y
    Front Immunol; 2022; 13():919979. PubMed ID: 35860285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early experience of COVID-19 vaccine-related adverse events among adolescents and young adults with rheumatic diseases: A single-center study.
    Haslak F; Gunalp A; Cebi MN; Yildiz M; Adrovic A; Sahin S; Barut K; Kasapcopur O
    Int J Rheum Dis; 2022 Mar; 25(3):353-363. PubMed ID: 34978376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline factors associated with self-reported disease flares following COVID-19 vaccination among adults with systemic rheumatic disease: results from the COVID-19 global rheumatology alliance vaccine survey.
    Rider LG; Parks CG; Wilkerson J; Schiffenbauer AI; Kwok RK; Noroozi Farhadi P; Nazir S; Ritter R; Sirotich E; Kennedy K; Larche MJ; Levine M; Sattui SE; Liew JW; Harrison CO; Moni TT; Miller AK; Putman M; Hausmann J; Simard JF; Sparks JA; Miller FW;
    Rheumatology (Oxford); 2022 Jun; 61(SI2):SI143-SI150. PubMed ID: 35460240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 vaccination and infection status: a cross-sectional survey of patients with rheumatic diseases in China.
    Chen C; Huang S; Geng L; Lai P; Dou H; Zhang H; Chen H; Liang J; Sun L
    Rheumatol Int; 2024 Apr; 44(4):703-713. PubMed ID: 37897662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covid-19 vaccination in autoimmune rheumatic diseases: A multi-center survey from southern India.
    Mohanasundaram K; Santhanam S; Natarajan R; Murugesan H; Nambi T; Chilikuri B; Nallasivan S
    Int J Rheum Dis; 2022 Sep; 25(9):1046-1052. PubMed ID: 35773944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview-based survey.
    Gaur P; Agrawat H; Shukla A
    Rheumatol Int; 2021 Sep; 41(9):1601-1605. PubMed ID: 34213580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of COVID-19 and Influenza Vaccination on Rheumatic Diseases: Results From a Survey of Patient-Reported Outcomes After Vaccination.
    Kim JW; Jung JY; Suh CH; Ye YM; Kim HA
    J Korean Med Sci; 2023 Aug; 38(32):e247. PubMed ID: 37582497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceived Risk of SARS-CoV-2 at the Start of the COVID-19 Pandemic and Subsequent Vaccination Attitudes in Patients With Rheumatic Diseases: A Longitudinal Analysis.
    Duculan R; Mancuso CA
    J Clin Rheumatol; 2022 Jun; 28(4):190-195. PubMed ID: 35067512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic rheumatic disease flares after SARS-CoV-2 vaccination among rheumatology outpatients in New York City.
    Barbhaiya M; Levine JM; Bykerk VP; Jannat-Khah D; Mandl LA
    Ann Rheum Dis; 2021 Oct; 80(10):1352-1354. PubMed ID: 34158370
    [No Abstract]   [Full Text] [Related]  

  • 11. Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs.
    De Stefano L; Balduzzi S; Bogliolo L; D'Onofrio B; di Lernia M; Mauric E; Milanesi A; Brandolino F; Rocca C; Chiricolo S; Manzo A; Montecucco C; Bugatti S
    Clin Exp Rheumatol; 2023 Mar; 41(3):667-675. PubMed ID: 36135948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicentre case-control study evaluating the safety of anti-SARS-CoV-2 vaccines in a cohort of patients with systemic vasculitis.
    Simoncelli E; Conticini E; Colafrancesco S; Gattamelata A; Spinelli FR; Garufi C; Truglia S; Grazzini S; Giardina F; Izzo R; Cantarini L; Frediani B; Conti F; Priori R
    Clin Exp Rheumatol; 2023 Apr; 41(4):922-927. PubMed ID: 37073636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and disease flare of autoimmune inflammatory rheumatic diseases: a large real-world survey on inactivated COVID-19 vaccines.
    Fan Y; Geng Y; Wang Y; Deng X; Li G; Zhao J; Ji L; Zhang X; Song Z; Zhang H; Sun X; Gao D; Xie W; Huang H; Hao Y; Zhang Z
    Ann Rheum Dis; 2022 Mar; 81(3):443-445. PubMed ID: 34824048
    [No Abstract]   [Full Text] [Related]  

  • 14. Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines.
    Schulze-Koops H; Specker C; Skapenko A
    RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry.
    Lawson-Tovey S; Machado PM; Strangfeld A; Mateus E; Gossec L; Carmona L; Raffeiner B; Bulina I; Clemente D; Zepa J; Rodrigues AM; Mariette X; Hyrich KL;
    RMD Open; 2022 Jul; 8(2):. PubMed ID: 35908834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of SARS-CoV-2 vaccination in patients with Behcet's syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccine.
    Ozdede A; Guner S; Ozcifci G; Yurttas B; Toker Dincer Z; Atli Z; Uygunoğlu U; Durmaz E; Uçar D; Uğurlu S; Saip S; Tabak F; Hamuryudan V; Seyahi E
    Rheumatol Int; 2022 Jun; 42(6):973-987. PubMed ID: 35376962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptom flares after COVID-19 infection versus vaccination among youth with PANS/PANDAS.
    LaRusso MD; Abadia CE
    Allergy Asthma Proc; 2023 Sep; 44(5):361-367. PubMed ID: 37641227
    [No Abstract]   [Full Text] [Related]  

  • 18. Autoimmune inflammatory rheumatic diseases post-COVID-19 vaccination.
    Safary A; Esalatmanesh K; Eftekharsadat AT; Jafari Nakjavani MR; Khabbazi A
    Int Immunopharmacol; 2022 Sep; 110():109061. PubMed ID: 35978510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study.
    Fragoulis GE; Bournia VK; Mavrea E; Evangelatos G; Fragiadaki K; Karamanakos A; Kravariti E; Laskari K; Panopoulos S; Pappa M; Mitsikostas DD; Tektonidou MG; Vassilopoulos D; Sfikakis PP
    Rheumatol Int; 2022 Jan; 42(1):31-39. PubMed ID: 34739573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 Vaccination Perceptions in Patients With Rheumatic Disease: A Cross-Sectional Online Survey.
    Butt IN; van Eeden C; Burns KK; Saxinger L; Clifford A; Tervaert JWC; Yacyshyn EA
    J Rheumatol; 2023 May; 50(5):690-696. PubMed ID: 36521919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.